Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Palleon Pharmaceuticals' E-602, combined with cemiplimab, demonstrates potential in treating anti-PD-(L)1-resistant solid tumors in a Phase I/II trial.
Palleon Pharmaceuticals presented Phase 1/2 GLIMMER-01 trial results of E-602 with cemiplimab in patients with PD-(L)1-resistant solid tumors.